ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models.

Pharmaceutics · 2021 · PMC8779833 · PMID 35056985

Europe PMC DOI

hedged sentences

0.0100

closest p · 0.2× alpha

0.0500

boldest claim

The sentences

highly significantp = 0.01actually significant

However, compared to free GT, the GT DcNP-LFA1-P exhibited highly significant treatment effects ( p = 0.01; GT DcNP-LFA1-P vs. free drug), and a lower degree of significance for GT DcNPs ( p = 0.04 GT DcNP vs. free drug).

also in 132,142 other papers

did not reach statistical significancep > 0.05actually significant

Due to the small sample size, the data variation did not reach statistical significance ( p > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.